The mechanisms underlying the benefits of activin-A/ActRII inhibition in HF are multifold, encompassing effects on proteostasis, Ca2+ handling, fibrosis, energetics, metabolism, and senescence. The gene discussed is ACVR2A; the disease is hydrops fetalis.